Divi's Laboratories Ltd DIVISLAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹5,430.30
- Day Range
- ₹5,385.25–5,522.20
- 52-Week Range
- ₹3,295.30–5,582.95
- Bid/Ask
- ₹5,425.55 / ₹5,425.55
- Market Cap
- ₹1.44 Tril
- Volume/Avg
- 524,300 / 682,308
Key Statistics
- Price/Earnings (Normalized)
- 86.14
- Price/Sales
- 17.70
- Dividend Yield (Trailing)
- 0.55%
- Dividend Yield (Forward)
- 0.55%
- Total Yield
- 0.55%
Company Profile
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 17,524
- Website
- https://www.divislabs.com
Comparables
Valuation
|
Metric
|
DIVISLAB
|
543434
|
532815
|
|---|---|---|---|
Price/Earnings (Normalized) | 86.14 | 33.42 | 54.06 |
Price/Book Value | 10.61 | 5.62 | 6.08 |
Price/Sales | 17.70 | 7.82 | 4.19 |
Price/Cash Flow | 77.19 | 35.27 | 37.24 |
Price/Earnings
DIVISLAB
543434
532815
Financial Strength
|
Metric
|
DIVISLAB
|
543434
|
532815
|
|---|---|---|---|
Quick Ratio | 4.74 | 2.47 | 0.86 |
Current Ratio | 7.57 | 5.17 | 1.61 |
Interest Coverage | 659.00 | 51.09 | 4.55 |
Quick Ratio
DIVISLAB
543434
532815
Profitability
|
Metric
|
DIVISLAB
|
543434
|
532815
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
DIVISLAB
543434
532815
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bgyfgpth | Hzcft | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Cwspqswxw | Pmszdc | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Wspyzzws | Wwhsy | $46.6 Bil | |||
| Viatris Inc
VTRS
| Fkwwqrmk | Jkv | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fffnffjw | Pxwkp | $13.2 Bil | |||
| Catalent Inc
CTLT
| Spmzxxdqs | Rsjhb | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Hfcqthck | Syydvkd | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Gctlpjyjv | Twx | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Lwyqfxpb | Fcbm | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Dmxwccxg | Jxwj | $2.2 Bil |
United States